These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28962997)

  • 1. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
    Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
    Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessing the need for active surveillance of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the neonatal intensive care population.
    Song X; Soghier L; Floyd TT; Harris TR; Short BL; DeBiasi RL
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1436-1441. PubMed ID: 30345942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
    Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
    J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
    Prevel R; Boyer A; M'Zali F; Lasheras A; Zahar JR; Rogues AM; Gruson D
    Crit Care; 2019 May; 23(1):170. PubMed ID: 31088542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
    Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Hospital-Acquired Carriage of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Among Patients in Dutch Hospitals.
    Kluytmans-van den Bergh MFQ; van Mens SP; Haverkate MR; Bootsma MCJ; Kluytmans JAJW; Bonten MJM;
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):32-39. PubMed ID: 29215330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial.
    Maechler F; Schwab F; Hansen S; Fankhauser C; Harbarth S; Huttner BD; Diaz-Agero C; Lopez N; Canton R; Ruiz-Garbajosa P; Blok H; Bonten MJ; Kloosterman F; Schotsman J; Cooper BS; Behnke M; Golembus J; Kola A; Gastmeier P;
    Lancet Infect Dis; 2020 May; 20(5):575-584. PubMed ID: 32087113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Intestinal Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae in Critically Ill Patients: Expected Benefits and Evidence-based Controversies.
    Zahar JR; Blot S; Nordmann P; Martischang R; Timsit JF; Harbarth S; Barbier F
    Clin Infect Dis; 2019 May; 68(12):2125-2130. PubMed ID: 30312366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-spectrum beta-lactamase--producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission.
    Alves M; Lemire A; Decré D; Margetis D; Bigé N; Pichereau C; Ait-Oufella H; Baudel JL; Offenstadt G; Guidet B; Barbut F; Maury E
    BMC Infect Dis; 2016 Apr; 16():147. PubMed ID: 27075040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
    Razazi K; Derde LP; Verachten M; Legrand P; Lesprit P; Brun-Buisson C
    Intensive Care Med; 2012 Nov; 38(11):1769-78. PubMed ID: 22893223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
    Kim J; Lee JY; Kim SI; Song W; Kim JS; Jung S; Yu JK; Park KG; Park YJ
    Ann Lab Med; 2014 Jan; 34(1):20-5. PubMed ID: 24422191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.
    Jolivet S; Lolom I; Bailly S; Bouadma L; Lortat-Jacob B; Montravers P; Armand-Lefevre L; Timsit JF; Lucet JC
    J Hosp Infect; 2020 May; 105(1):10-16. PubMed ID: 32092367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
    Detsis M; Karanika S; Mylonakis E
    Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.
    Grohs P; Podglajen I; Guerot E; Bellenfant F; Caumont-Prim A; Kac G; Tillecovidin B; Carbonnelle E; Chatellier G; Meyer G; Fagon JY; Gutmann L
    Clin Microbiol Infect; 2014 Nov; 20(11):O879-86. PubMed ID: 24807791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended spectrum beta-lactamase producing
    Prevel R; Boyer A; M'Zali F; Cockenpot T; Lasheras A; Dubois V; Gruson D
    Antimicrob Resist Infect Control; 2019; 8():112. PubMed ID: 31333839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
    Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
    Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Discontinuing Contact Precautions for MRSA and ESBLE in an Intensive Care Unit: A Prospective Noninferiority Before and After Study.
    Renaudin L; Llorens M; Goetz C; Gette S; Citro V; Poulain S; Vanson ML; Sellies J
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1342-1350. PubMed ID: 28927475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
    Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
    J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital.
    Shimasaki T; Segreti J; Tomich A; Kim J; Hayden MK; Lin MY;
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1058-1062. PubMed ID: 30022738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
    PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.